S. Kakkar

Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.

M. Stringer, V. Kakkar, C. Parker, 1989, American journal of surgery.

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery

V. Kakkar, S. Das, M. J. Phillips, 1993, The Lancet.

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery

V. Kakkar, S. Das, M. J. Phillips, 1993, The Lancet.

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group.

V. Kakkar, S. Das, M. J. Phillips, 1993, Lancet.

Efficacy and safety of two regimens of low molecular weight heparin fragment (Fragmin) in preventing postoperative venous thrombolism.

V. Kakkar, R. M. Sanderson, S. Kakkar, 1986, Haemostasis.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Mehrad Amin Eskandari, J. F. Tinto, A. Capucci, 2018, Indian heart journal.

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Michael A. Rodriguez, M. S. Lee, S. W. Park, 2019, Journal of the American Heart Association.

What pharma wants.

S. Kakkar, E. Steiness, A. Warrander, 2007, Nature biotechnology.

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Michael A. Rodriguez, Y. Y. Liu, J. F. Tinto, 2019, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.